Pulmonary Embolism
An Introduction to Pulmonary Embolism
Beyond anticoagulation, interest has grown in therapeutic escalation through systemic thrombolysis, catheter-directed therapies or surgical embolectomy in patients with high- and intermediate risk pulmonary embolism (PE). An ultrasound-assisted thrombolysis system, as well as catheter-based embolectomy and bioconvertible inferior vena cava filter interventional devices have been approved for use in recent years. It is hoped that more information will emerge to support selection of interventions for medium- and high-risk PE patients.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
As touchRESPIRATORY approaches 10 years of providing education for busy respiratory specialists, we are looking to the future—and it certainly looks bright!
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases, which covers several hot topics in respiratory medicine, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, bronchiectasis and the ever-present subject of Coronavirus Disease 2019 (COVID-19). The ...
Cannabis use disorder is described as the inability to stop using marijuana, despite a negative impact on health. It was a pleasure to talk with Dr. Advait Vasavada (M. P. Shah Medical College, Jamnagar, India) around the aims, design, eligibility ...
Cannabis use disorder is described as the inability to stop using marijuana, despite a negative impact on health. We caught up with Dr. Advait Vasavada (M. P. Shah Medical College, Jamnagar, India) around the definition of cannabis use disorder and ...
Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases, which aims to provide insightful and topical articles relevant to the everyday practice of busy physicians. Our popular expert interviews provide a snapshot of hot topics in medicine. ...
Luis Jara-Palomares, from Seville, Spain, joins us at ERS 2019 in Madrid, to discuss the main findings from his study into the significance of environmental factors in pulmonary embolism and pulmonary arterial hypertension. Questions 1. What are the major causes of pulmonary ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
